Keyphrases
Acid Concentration
5%
Adjuvant-free
7%
Adverse Reactions
8%
Anti-PEG Antibodies
35%
Anti-PEG IgM
7%
Antibiotic Treatment
11%
Antibiotics
22%
Antigen-specific Immune Response
7%
Antigen-specific Response
35%
Before Pregnancy
35%
Butyric Acid
5%
Butyric Acid-producing Bacteria
5%
Carrier Protein
7%
CD4+ T Cells
42%
Cecal Contents
5%
Combination Vaccine
8%
COVID-19
14%
CpG ODN
70%
Dietary Vitamins
8%
DNA Methylation (DNAm)
5%
Effective Strategies
5%
Environmental Factors
5%
Eosinophilia
35%
Epigenetic Modification
35%
F1 Progeny
5%
Fecal Excretion
5%
Food Allergy
35%
Food-related
5%
Fusion Protein
35%
Glycolate
35%
Glycoprotein
35%
Gut Microbiome
35%
Gut Microbiota
61%
Gut Microbiota Composition
5%
H5N1 Virus
7%
Hemagglutinin
35%
Highly Effective
10%
Host Immune Response
5%
Infected Mice
7%
Infectious Diseases
14%
Influenza Virus
14%
Initial Infection
7%
Intestinal Lamina Propria
5%
Intranasal Immunization
35%
Intranasal Vaccine
35%
Ionizable Lipids
7%
Lamina Propria Lymphocytes
5%
Later Life
5%
Lower Respiratory Tract
11%
Lower Respiratory Tract Infection
5%
Lung
8%
Lung Tissue Damage
5%
Lung Weight
25%
Maternal Environment
5%
Maternal Microbiome
35%
Messenger RNA Vaccine
31%
Metabolism
35%
Methylation Status
11%
MRNA-LNP
31%
Mucosal IgA
7%
Mucosal Immunity
7%
Nanoparticle Vaccine
15%
Neutralizing Antibodies
5%
Non-glycosylated
35%
Novel Environment
5%
Novel Fusion
5%
Offspring Health
5%
Older Adults
5%
Pre-existing Immunity
35%
Previous Infection
7%
Protein Vaccine
35%
Receptor-binding Domain
35%
Recombinant Glycoprotein
52%
Respiratory Syncytial Virus
64%
Respiratory Syncytial Virus Infection
35%
SARS-CoV-2 Infection
7%
Serum IgE
11%
Severe Respiratory Failure
5%
Specific Antibodies
17%
Stress Response
5%
Subsequent Generations
35%
Surface Antigen
5%
Systemic Immunity
7%
T Helper 1
20%
T Helper 2
5%
Upper Respiratory Tract
39%
Vaccination
11%
Vaccine Antigen
11%
Vaccine Effectiveness
7%
Vaccine Platform
21%
Vaccine Target
17%
Virus Challenge
38%
Vitamin B2
35%
Immunology and Microbiology
Adjuvant
16%
Adoptive Immunity
11%
Antibodies
24%
Antigen Specificity
63%
Blood Plasma
5%
Conception
5%
COVID-19
11%
CpG Oligodeoxynucleotide
70%
Cytokine
11%
DNA Methylation
5%
Epigenetic Modification
35%
Food Allergy
35%
Glycoprotein
70%
Hemagglutinin
35%
Human Respiratory Syncytial Virus
64%
Immune Response
42%
Immunocompetent Cell
5%
Immunoglobulin A
7%
Immunoglobulin E
5%
Immunoglobulin M
11%
Immunology
10%
Infectious Disease
14%
Influenzavirus A
14%
Intestine Flora
70%
Lamina Propria
5%
Lower Respiratory Tract
17%
Lung Weight
35%
Lymphocyte
5%
Membrane Antigen
5%
Membrane Transport Protein
7%
Metabolite
5%
Methylation
5%
Microbial Metabolism
35%
Microorganism
5%
Mucosal Immunity
7%
Neutralizing Antibody
17%
Progeny
20%
Pulmonary Inflammation
6%
Receptor Binding
35%
Respiratory Syncytial Virus Infection
35%
RNA Vaccine
35%
Severe Acute Respiratory Syndrome Coronavirus 2
21%
Spike
7%
Systemic Immunity
7%
T Helper 1 Cell
18%
T Helper 2 Cell
5%
T-Helper Cell
42%
Upper Respiratory Tract
38%
Pharmacology, Toxicology and Pharmaceutical Science
Adjuvant
9%
Adverse Event
6%
Antibiotics
5%
Antibodies
12%
Combination Vaccine
6%
CpG Oligodeoxynucleotide
70%
Eosinophilia
35%
Folic Acid
5%
Glycolic Acid
35%
Glycoprotein
70%
Guanine Nucleotide Binding Protein
38%
Human Respiratory Syncytial Virus
100%
Immunopathology
5%
Interleukin 13
35%
Intestine Flora
35%
Membrane Antigen
5%
Microorganism
35%
Mucin
35%
Neutralizing Antibody
5%
Pneumonia
6%
Respiratory Syncytial Virus Infection
35%
Respiratory Tract
38%
Respiratory Tract Disease
47%
Riboflavin
23%
Riboflavin Deficiency
35%
Tissue Injury
5%
Vitamin B12
5%
Vitamin Deficiency
5%